Urology · East Chicago, IN
NPI
1295078418
Since 2013
Specialty
Urology
Code 208800000X
Group practices
4
Medicare group memberships
Hospitals
6
Hospital affiliations
4320 Fir Street, Suite 220
East Chicago, IN, 46312
Phone (219) 703-2591
Groups this clinician bills Medicare through
Medicare paid, 2024
$416K
13,109 services
Medicare patients, 2024
1,118
Average age 76
Drug cost, 2024
$2.5M
2,978 prescriptions
Company payments, 2025
$2,264
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Priyanka Kumar was code J0585 (injection, onabotulinumtoxina, 1 unit), 4,950 times for 32 patients. In total Priyanka Kumar billed 13,109 services in 69 codes, and Medicare paid $416K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 4,950 | 32 | $4.84 | $24K |
| 81003 Clinical Chemistry | Office | 1,142 | 732 | $2.19 | $2,501 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,125 | 761 | $11.30 | $13K |
| 51798 Ultrasound - Nonspecific | Office | 669 | 498 | $7.57 | $5,068 |
| 99214 Office E&M - Established | Office | 558 | 373 | $86.56 | $48K |
| 99213 Office E&M - Established | Office | 489 | 406 | $61.02 | $30K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 192 | 22 | $140.81 | $27K |
| 99204 Office E&M - New | Office | 161 | 161 | $108.51 | $17K |
| 99232 Hospital E&M - Subsequent | Facility | 140 | 108 | $56.85 | $7,959 |
| 52000 Cystourethroscopy | Office | 131 | 121 | $167.73 | $22K |
| 81001 Clinical Chemistry | Office | 93 | 84 | $2.84 | $264 |
| 99203 Office E&M - New | Office | 67 | 67 | $69.52 | $4,658 |
| 99215 Office E&M - Established | Office | 60 | 30 | $123.17 | $7,390 |
| 99211 Office E&M - Established | Office | 47 | 43 | $15.96 | $750 |
| 52287 Cystourethroscopy | Office | 41 | 32 | $273.90 | $11K |
By year: 2022 $133K for 3,207 services; 2023 $552K for 6,327 services; 2024 $416K for 13,109 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,142 | 732 | $2.19 | $2,501 |
| 81001 Clinical Chemistry | 93 | 84 | $2.84 | $264 |
Medicare prescription drug claims, 2024
In 2024, the drug Priyanka Kumar prescribed most often to Medicare patients was Solifenacin Succinate, with 441 prescriptions and refills. In total Priyanka Kumar wrote 2,978 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Solifenacin Succinate Generic | 441 | 793 | 130 | $35K |
| Gemtesa Vibegron | 326 | 533 | 72 | $255K |
| Tamsulosin Hcl Generic | 322 | 733 | 96 | $4,072 |
| Trospium Chloride Generic | 211 | 335 | 79 | $14K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 203 | 215 | 118 | $714 |
| Estradiol Generic | 192 | 503 | 108 | $7,938 |
| Cephalexin Generic | 166 | 204 | 89 | $957 |
| Myrbetriq Mirabegron | 141 | 223 | 41 | $100K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 139 | 231 | 33 | $3,864 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 92 | 120 | 50 | $2,215 |
| Finasteride Generic | 90 | 198 | 23 | $1,152 |
| Amitriptyline Hcl Generic | 80 | 102 | 14 | $614 |
| Erleada Apalutamide | 66 | 68 | Under 11 | $1.0M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 61 | 61 | 55 | $321 |
| Xtandi Enzalutamide | 58 | 58 | Under 11 | $804K |
Brand drugs: 709 claims; generic drugs: 2,269 claims; opioid claims: 69.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Priyanka Kumar $2,264 ($2,264 in general payments such as food, travel and fees) from 22 companies. The largest payer was Sumitomo Pharma America, Inc. with $293.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 18 | $293 |
| Caldera Medical, Inc | 1 | $270 |
| Astellas Pharma US Inc 4503.T | 9 | $256 |
| Abbvie Inc. ABBV | 11 | $245 |
| Dendreon Pharmaceuticals LLC | 9 | $226 |
| Janssen Biotech, Inc. JNJ | 7 | $182 |
| Urogen Pharma, Inc. URGN | 5 | $142 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $109 |
| Coloplast Corp | 4 | $99.03 |
| Calyxo, Inc. | 3 | $62.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.